Literature DB >> 31788577

Congenital giant orbital eccrine hidrocystoma.

Raghad Al Rasheed1, Mazen AlSamnan2.   

Abstract

PURPOSE: To describe the clinical presentation, management, and histopathological results of a congenital eccrine hidrocystoma. OBSERVATIONS: A 4-year-old healthy boy presented with left upper eyelid ptosis and superonasal painless mass since birth. Computed tomography showed a hypodense cystic lesion located in the extraconal orbital compartment medially. Following complete excision, histopathology revealed an eccrine hidrocystoma. CONCLUSIONS AND IMPORTANCE: Orbital eccrine hidrocystomas should be considered in the differential diagnosis of orbital cystic masses in the pediatric age group.
© 2019 The Authors.

Entities:  

Keywords:  Eccrine; Hidrocystoma; Orbital cystic mass

Year:  2019        PMID: 31788577      PMCID: PMC6880129          DOI: 10.1016/j.ajoc.2019.100570

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


Introduction

Hidrocystomas are benign cutaneous cystic lesions that arise from eccrine or apocrine sweat glands that are located in the periocular area. They account for 5% of all eyelid tumors in adults and 1% in children, and it rarely arises in the orbital cavity., As for eccrine hidrocystomas, they are usually located in the head/neck region and can manifest as a single or multiple small cyst. However, giant lesions situated in the orbital area are rarely reported, and their presentation is predominant in young infants.,, This report describes the clinical presentation, management, and histopathological results of a congenital giant orbital eccrine hidrocystoma. Despite its scarce presentation, orbital eccrine hidrocystoma should be in the differential diagnosis of orbital cysts in all age groups. Early management in the pediatric group is of significant concern to prevent amblyopia.

Case report

A 4-year-old boy presented with left upper eyelid ptosis and superonasal mass since birth. He is a healthy full-term boy with normal delivery and no significant past medical history. The parents denied any complaints of pain or change in the size of the mass. On examination, uncorrected visual acuity was 20/30 right eye, 20/70 left eye. Mechanical left upper eyelid ptosis was noted to be secondary to a superonasal swelling (Fig. 1A). No skin changes were noted over the area. The mass was non-pulsatile, non-tender, soft, freely mobile with no attachment to adjacent tissue. No discharge or tear reflux was noted on digital palpation. Both pupils were reactive to light with no afferent pupillary defect. Extraocular motility was full at all gazes without any restrictions. Slit lamp and fundus examinations were normal. Autorefraction was as follows: +0.75–1.00 × 173 for the right eye compared to a high astigmatic error in the left eye: −8.75–8.75 × 31. B-scan ultrasound demonstrated a fluid-filled cavity with no internal echoes (Fig. 2). Computed tomography (CT) revealed a well-defined, hypodense cystic lesion located in the extraconal orbital compartment medially. Also, there was a mild compression of the left orbit and minimal remodeling to the adjacent bone (Fig. 3). The patient underwent anterior orbitotomy through lid crease incision to excise the mass (Fig. 4). The cyst was excised intact and gross examination of the mass revealed a delicate smooth wall, filled with clear fluid. Histopathologic evaluation revealed a 1.5 × 2.2 × 1.9 cm cystic lesion with a clear cavity lined by a smooth surface of a double layer of cuboidal cells. No apical snouts were identified which is consistent with the diagnosis of eccrine hidrocystoma. (Fig. 5).
Fig. 1

An external photograph showing left upper eyelid superonasal mass causing mechanical ptosis. (A); Post-operative appearance at 1-month follow-up visit. (B).

Fig. 2

B-scan ultrasound demonstrate: anechogenic fluid-filled cavity (arrow), normal composition of left globe (asterisk).

Fig. 3

A computed tomography scan of the orbit showing a well-defined, hypodense cystic lesion located in the medial wall of the left orbit.

Fig. 4

An intraoperative photograph demonstrating surgical excision of the cystic mass through anterior orbitotomy through an upper eyelid crease incision.

Fig. 5

Histopathologic cross-section of the mass stained with hematoxylin and eosin stain. Low magnification: unilocular cystic space lined by 2 layers of cuboidal cells. (A); High magnification: the lining epithelium is double layered cuboidal to flattened cells slightly eosinophilic cytoplasm and basally located round to oval nucleus. (B).

An external photograph showing left upper eyelid superonasal mass causing mechanical ptosis. (A); Post-operative appearance at 1-month follow-up visit. (B). B-scan ultrasound demonstrate: anechogenic fluid-filled cavity (arrow), normal composition of left globe (asterisk). A computed tomography scan of the orbit showing a well-defined, hypodense cystic lesion located in the medial wall of the left orbit. An intraoperative photograph demonstrating surgical excision of the cystic mass through anterior orbitotomy through an upper eyelid crease incision. Histopathologic cross-section of the mass stained with hematoxylin and eosin stain. Low magnification: unilocular cystic space lined by 2 layers of cuboidal cells. (A); High magnification: the lining epithelium is double layered cuboidal to flattened cells slightly eosinophilic cytoplasm and basally located round to oval nucleus. (B). At 1-month follow up visit, the patient was asymptomatic with no signs of recurrence (Fig. 1B). Visual acuity improved to 20/50 with a noticeable improvement in astigmatic error in the left eye tested by autorefraction: −4.25–2.25 × 10.

Discussion

Hidrocystoma can originate from eccrine or apocrine sweat glands. It accounts for 5% of all eyelid tumors in adults and 1% in children. Both genders can experience solitary hidrocystoma, whereas multiple lesions usually show a marked female propensity. Eccrine hidrocystomas are ductal retention cysts of obstructed sweat glands that cluster in the periocular area not involving the lid margin. On the other hand, the apocrine subtype develops from a cystic proliferation of the secretory glands of moll located in the eyelid margin. Epithelial cell sequestration at the embryonic stage could give rise to such congenital lesions. For acquired cases, theories suggest epithelial cell implantation into the orbit secondary to trauma or orbital surgeries. Due to similarities in the clinical picture, a histopathology study is vital in differentiating both subtypes. Eccrine hidrocystomas constitute of unilocular cysts lined with one or two layers of cuboidal cells. While the apocrine type characterized by papillary projections growing into the cystic cavity with decapitation secretion from the apocrine cells. Both subtypes should be differentiated from other cystic lesions, including mucoid cysts, inclusion cysts, basal cell carcinomas, lymphangioma, and hemangioma. With a large congenital nasal orbital mass, ruling out a meningoencephalocele is in consideration with this case, where bony defects are better visualized by CT. A major advantage of CT is its ability to image bone, soft tissue and blood vessels all at the same time. Ultrasound with doppler evaluation of the orbit obtains dynamic information, is readily available in many ophthalmic centers, and does not expose patients to radiation. For that, we elected to choose CT along with orbital ultrasound to determine the consistency of the mass, the extension, and to plan the surgical approach for our case. However, a histopathological biopsy remains the mainstay confirmatory test for diagnosis. A thorough review of the reported cases showed a total of 10 cases of periocular eccrine hidrocystoma; only 5 were orbital in origin (Table 1). In addition to the present case, to the best of our knowledge, only two cases of congenital eccrine hidrocystoma have been reported so far, (Table 1). Malihi et al. operated on a 2-month-old boy with an orbital eccrine hidrocystoma presented with a bluish nodular non-tender subconjunctival swelling since birth. Also, they reported another case as an idiopathic orbital eccrine hidrocystoma in an 8-year-old boy presented with proptosis and limitation in abduction. Eslami et al. reported a 14-year-old girl with a painless medial canthal cyst for 3 months which was diagnosed as idiopathic orbital eccrine hidrocystoma. A giant lesion has been previously reported in the superior part of the orbit causing inferior dystopia and posterior eyelid lamellar inversion.
Table 1

The reported cases of eccrine hidrocystoma.

No.Author & YearAgea/GenderPresenting symptomsCyst sizeOriginRadiologic features
Eyelid
1Feijó et al.1673/FBilateral multiple tumors on both eyelids.NAAcquiredNA
2Hirata 201392/MUpper eyelid tumor with no pain or inflammation. The lesion was in direct contact with the tarsal plate. Ptosis and oblique astigmatism developed two years later.1.2 × 1.2 × 0.8 cmCongenitalT2-enhanced MRI: a well-demarcated lesion from the surrounding tissue.
3Kumar et al. 201769/FA painless, progressive drooping right eyelid.2.5 × 1.5 cmAcquiredB-scan: a fluid-filled cavity with no internal echoes.CT: cyst without bone erosion.
4Sarabi and Khachemoune1769/MA small, clear, cystic fluid-filled papule in the left upper eyelid.0.4 × 0.3 cmAcquiredNA
5Sheth et al. 20081855/FMass, discharge, tearing and ectropion.2 cmAcquiredNA
Orbital
6Eslami et al. 20071014/FUpper eyelid mass for 3 months without any pain or any other symptoms.1 × 1 × 2.5 cmAcquiredCT: an extraconal mass above the medial rectus muscle, mild enhancement. No bone erosion.
7Malihi et al. 201512 months/MMedial canthal superficial mass, no other symptoms.SmallCongenitalNA
8Malihi et al. 201518/MSupra-temporal deep orbital mass with inferior globe displacement and 2 mm proptosis, no diplopia or visual loss.LargeAcquiredCT: an erosion of the lateral orbital wall.MRI: isointense in T1 and hyperintense in T2.
9Marangoz et al. 20161929/FA painless, progressive mass.1.5 × 1.5 × 0.6 cmAcquiredMRI: mildly hyperintense on T1 and hyperintense on T2, and showed no enhancement pattern.
10Palama et al. 20151157/FUpper eyelid swelling and pain. Entropion, large central corneal epithelial erosion causing irritation and epiphora. Inferior globe displacement, restricted downgaze.2.5 × 2 × 2 cmAcquiredMRI: extraconal large cyst with an anterior extension towards the eyelid.
11The present case4/MA superonasal mass with ptosis.1.5 × 2.2 × 1.9 cmCongenitalB-scan: anechogenic fluid-filled cavity.CT: a hypodense cystic lesion located in the extraconal orbital compartment medially.

Expressed in years unless otherwise specified. CT: Computed Tomography; F: Female; M: Male; MRI: Magnetic Resonance Imaging; NA: Not Available.

The reported cases of eccrine hidrocystoma. Expressed in years unless otherwise specified. CT: Computed Tomography; F: Female; M: Male; MRI: Magnetic Resonance Imaging; NA: Not Available. Careful excision with complete removal of the cyst wall is advocated for large hidrocystomas to prevent the regrowth from remnant parts., On the other hand, small asymptomatic hidrocystomas can be observed though spontaneous resolution is rare. For the pediatric-age group, prompt management is essential to prevent amblyopia. It can develop directly from occlusion of the visual axis, or indirectly from the development of astigmatism secondary to mass effect. Robb studied the refractive errors associated with hemangioma of the eyelids, found cylinders of 1.5–7 D in 44% of patients. Stigmar et al. reported similar errors in 20% of his studied sample. They both stated that plus cylinder axes correspond to hemangioma site., Our findings support their statement.

Conclusion

Eccrine hidrocystomas are benign ductal retention cysts of obstructed sweat glands that can rarely develop in the orbital cavity. The lesion presents as a painless mass with various symptoms according to location and size. It is managed by a complete excision and histopathological confirmation. Prompt management in the pediatric age group is essential to prevent amblyopia. This entity should be in the differential diagnosis of orbital cysts in all age groups.

Patient consent

Written informed general consent was obtained from the parents, which includes using patient's anonymous information.

Authorship

All authors attest that they meet the current ICMJE criteria for authorship.

Funding

No funding or grant support.

Declaration of competing interest

The authors declared that there is no conflict of interest.
  16 in total

1.  Recurrent giant orbital apocrine hidrocystoma.

Authors:  I C Ssi-Yan-Kai; A R Pearson
Journal:  Eye (Lond)       Date:  2012-04-13       Impact factor: 3.775

Review 2.  Multiple eccrine hidrocystomas of the face.

Authors:  A Alfadley; K Al Aboud; A Tulba; M M Mourad
Journal:  Int J Dermatol       Date:  2001-02       Impact factor: 2.736

Review 3.  Hidrocystomas--a brief review.

Authors:  Khashayar Sarabi; Amor Khachemoune
Journal:  MedGenMed       Date:  2006-09-06

4.  Giant eccrine hidrocystoma presenting with unilateral ptosis and epiphora.

Authors:  Hiten G Sheth; Jyoti Raina
Journal:  Int Ophthalmol       Date:  2007-10-06       Impact factor: 2.031

5.  Eccrine hidrocystoma of the eyelid.

Authors:  A D Singh; L McCloskey; M A Parsons; D N Slater
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

6.  Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit.

Authors:  G Stigmar; J S Crawford; C M Ward; H G Thomson
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

7.  Eccrine Hidrocystoma Arising at the Tarsal Plate during Childhood.

Authors:  Akira Hirata
Journal:  Case Rep Ophthalmol       Date:  2013-07-25

8.  Orbital Eccrine Hidrocystoma.

Authors:  Deniz Marangoz; Işın Doğan Ekici; Ferda Çiftçi
Journal:  Turk J Ophthalmol       Date:  2016-10-17

9.  Giant Hidrocystoma of the Orbit Presenting with Inversion and Ptosis of the Upper Eyelid.

Authors:  Melis Palamar; Banu Yaman; Taner Akalın; Ayşe Yağcı
Journal:  Turk J Ophthalmol       Date:  2017-04-01

10.  Giant eyelid eccrine hidrocystoma-induced progressive ptosis in childhood.

Authors:  Dhivya Ashok Kumar; Amar Agarwal
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.